Top Markets
Coin of the day
Encell Co. Ltd. Encell Co. Ltd.

Encell Co. Ltd.

456070
Rank in Stocks #25906
Based in Seoul, South Korea, Encell Co. Ltd., established in February 2018,... Based in Seoul, South Korea, Encell Co. Ltd., established in February 2018, focuses on the research, development, and manufacturing of biopharmaceuticals. The company offers tailored pharmaceutical development services, guiding projects from their initial concept through to regulatory approval.
Share Price
$4.11
Last synced: 2026-08-20
Market Cap
$45.26M
Change (1 day)
0.34%
Change (1 year)
-43.61%
Country
KR
Trade Encell Co. Ltd. (456070)

Category

P/E ratio for Encell Co. Ltd. (456070)
P/E ratio as of 2026 TTM: 0
According to Encell Co. Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Encell Co. Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
29.20 -
US
30.62 -
NL
32.46 -
AU
- -
CH
-7.93 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.